Jove
Visualize
Contact Us

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phytochemicals for Human Health: The Emerging Trends and Prospects, Part-3.

Current topics in medicinal chemistry·2024
Same author

Phytochemicals for Human Health: The Emerging Trends and Prospects, Part-2.

Current topics in medicinal chemistry·2024
Same author

Phytochemicals for Human Health: The Emerging Trends and Prospects.

Current topics in medicinal chemistry·2024
Same author

Tetrandrine for Targeting Therapy Resistance in Cancer.

Current topics in medicinal chemistry·2024
Same author

Pancreatic cancer: genetics, disease progression, therapeutic resistance and treatment strategies.

Journal of cancer metastasis and treatment·2023
Same author

Regulation of SPDEF expression by DNA methylation in advanced prostate cancer.

Frontiers in endocrinology·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 31, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.

Joshua J Steffan1, Hari K Koul

  • 1Program in Urosciences, Division of Urology, Department of Surgery, University of Colorado, Denver School of Medicine, Building P15 or RC2, MS: C317, 12700 E 19th Avenue, Aurora, CO 80045, USA.

Cancer Letters
|July 19, 2011
PubMed
Summary

Prostate-derived ETS factor (PDEF) is a unique transcription factor. Loss of PDEF expression correlates with increased tumor aggressiveness and metastasis, suggesting it may act as a tumor suppressor.

More Related Videos

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Related Experiment Videos

Last Updated: May 31, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Area of Science:

  • Molecular biology
  • Cancer research
  • Genetics

Background:

  • Prostate-derived ETS factor (PDEF) is a transcription factor unique within the ETS family.
  • PDEF is highly expressed in prostate tumor cells, regulating prostate-specific antigen (PSA) gene expression and acting as an androgen receptor co-regulator.
  • PDEF expression is restricted to epithelial cells in various tissues, including prostate, breast, colon, ovary, gastric, and airway epithelia.

Purpose of the Study:

  • To review the known functions and regulated gene products of PDEF.
  • To provide an overview of PDEF expression profiles in clinical tumor samples.
  • To explore the hypothesis that PDEF functions as a tumor metastasis suppressor.

Main Methods:

  • Literature review of PDEF research over the past decade.
  • Analysis of PDEF-regulated gene targets involved in tumor progression.
  • Examination of PDEF expression patterns in clinical tumor samples.

Main Results:

  • PDEF is a negative regulator of tumor progression and metastasis.
  • Loss of PDEF expression is observed in late-stage, advanced tumors, correlating with increased aggressiveness.
  • PDEF regulates numerous genes implicated in tumor cell invasion and metastasis.

Conclusions:

  • PDEF plays a significant role in suppressing tumor metastasis.
  • The loss of PDEF contributes to tumor aggressiveness.
  • Further investigation into PDEF-regulated genes and clinical expression is warranted to fully understand its tumor suppressor function.